Difference between revisions of "Part:BBa K4789002"
 
Line 17: Line 17:
 
===Usage and Biology===
 
===Usage and Biology===
  
 +
<!-- -->
 +
<!-- -->
 +
<span class='h3bb'>Sequence and Features</span>
 
<partinfo>BBa_K4789002 SequenceAndFeatures</partinfo>
 
<partinfo>BBa_K4789002 SequenceAndFeatures</partinfo>
 +
 +
  
  

Latest revision as of 08:29, 6 October 2023

pre-miR-22

A growing number of studies highlights the role of miR-22 in cervical cancer drug resistance development [1-3]. Pre-miR-22 basic part was used to overexpress miR-22 in Hela cells.


Reference

[1] Nejati Kazem,Alivand MohammadReza,Arabzadeh AmirAhmad,MicroRNA-22 in female malignancies: Focusing on breast, cervical, and ovarian cancers.[J] .Pathol Res Pract, 2021, 223: 153452.

[2]Konishi Hiromi,Hayashi Masami,Taniguchi Kohei et al. The therapeutic potential of exosomal miR-22 for cervical cancer radiotherapy.[J] .Cancer Biol Ther, 2020, 21: 1128-1135.

[3]Zhang Lu,Chen Bin,Ding Ding,Decreased microRNA-22 is associated with poor prognosis in cervical cancer.[J] .Int J Clin Exp Pathol, 2017, 10: 9515-9520.


Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]